The IFC conference was brim full of confident operators who, despite all the obstacles, are making money and seeing huge growth in private healthcare in Emerging Markets. We report on the new business models.
Seha Capital-backed Hassab Labs, the third largest Egyptian lab chain with 38 labs has signed a deal with Moroccan insurer Saham. So far it has set up two labs in Morocco and the plan is to add another three this year. Expect other countries to follow soon.
The International Finance Corporation, the investment arm of the World Bank, is one of the biggest investors in private sector healthcare in the Emerging Markets. We spoke to Mohandas about the IFC’s investment strategy in Sub-Saharan Africa (SSA).
Medical and pharmaceutical associations are urging Nigeria’s newly elected president Muhummadu Buhari to tackle the country’s limited health infrastructure and national insurance coverage. We speak to Segun Oguntoyinbo, managing director at healthcare consultancy Hanovia Medical, about the challenges.
Warburg Pincus has sold its 27% stake in Metropolis, the third largest Indian diagnostic lab chain, to the Shah family who run the business. Metropolis is also active in a half a dozen African countries and the UAE.
South Africa is embarking on an ambitious process of reform to redress its historic imbalance in healthcare delivery. The National Health Insurance policy envisions far-reaching change in both the payment and provision of healthcare. The enormously successful private sector, however, has been left in the dark over its future role. What does the future hold for this $30 billion private healthcare market?
Here we name and categorise the major investors in private healthcare services in the Developing World and get their view on the opportunities and problems they face. Developing World healthcare services have suddenly become wildly popular. New listed investment vehicles, such as GCC-based Amanat and Asian Healthcare Group in Malaysia have raised hundreds of millions of dollars with the promise of investing in healthcare services. Meanwhile, established private equity houses are launching funds worth up to $1bn and large healthcare services operators from Indonesia to Egypt are carrying out heavily oversubscribed IPOs on very high multiples.
One of the striking things about Richard Ajayi, boss of Nigerian healthcare group Therapia who we interview here, is the way he has formed a whole network of international alliances to bring healthcare services to Nigeria.
Healthcare service companies in emerging markets can tap into the knowledge and capacity of their opposite numbers in more developed markets. Therapia Health in Nigeria is a great example of this, with links to operators in Austria, Belgium, the UK, South Africa and India. Backed by a $5m investment from Abraaj, London-trained doctor Richard Ajayi has built an IVF clinic and lab chain and is now building a wider services platform.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
